Referring to the Prospectus (section 10.9), record date 3 months after IPO, exercise price $0.20 and expiry in November 2018. BGT will apply for options to be quoted on ASX.
"Shareholders who have sold Bio-Gene Shares before the record date will not be entitled to free Loyalty Options in respect of this Shares"
BGT Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
